MSD has confirmed that its
Atozet composite pack (ezetemibe
and atorvastatin) will be listed
on the Pharmaceutical Benefits
Scheme effective from 01 Dec.
The new composite pack
contains two tablets side by
side, in a calendar format which
simplifies administration with both
cholesterol lowering medications
packed together.
The company says this supports
compliance by helping patients on
dual therapy to remember to take
both tablets at the same time.
The Atozet composite pack also
results in cost savings for patients
who take both medications, with
a single PBS co-payment required
rather than two.The above article was sent to subscribers in Pharmacy Daily's issue from 13 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Nov 13
THE 87-year-old Amcal group has refreshed its brand tagline to ‘For you, for life’, as unveiled yesterday to over 240 members, suppliers and partners at the group’s national retail conference in Sydney.
AMID yesterday’s Amcal brand refresh announcement (see page one), parent company Sigma Healthcare is also readying for the 01 Jul start of its wholesale supply contract with Chemist Warehouse Group, worth at least $3 billion in revenue in the first full year (PD 06 Jun 2023).
OVER a quarter of a million people have sbeen vaccinated against influenza this year through community pharmacies in Queensland, reported the Pharmacy Guild of Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.